N-{[3-(10-methyl-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2-phenylacetamide
Chemical Structure Depiction of
N-{[3-(10-methyl-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2-phenylacetamide
N-{[3-(10-methyl-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2-phenylacetamide
Compound characteristics
| Compound ID: | G946-0033 |
| Compound Name: | N-{[3-(10-methyl-11-oxo-10,11-dihydrodibenzo[b,f][1,4]thiazepin-7-yl)-1,2,4-oxadiazol-5-yl]methyl}-2-phenylacetamide |
| Molecular Weight: | 456.52 |
| Molecular Formula: | C25 H20 N4 O3 S |
| Smiles: | CN1C(c2ccccc2Sc2cc(ccc12)c1nc(CNC(Cc2ccccc2)=O)on1)=O |
| Stereo: | ACHIRAL |
| logP: | 4.2876 |
| logD: | 4.2876 |
| logSw: | -4.3313 |
| Hydrogen bond acceptors count: | 8 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 70.981 |
| InChI Key: | PVAZBIMMIJGGKN-UHFFFAOYSA-N |